P2B-014

Stanford University (Stanford, CA) › P2B-014

P2B-014

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Stanford University (Stanford, CA) · Dr. Nolan
consented 2012-06-26

completed

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 3 abdominal pain with onset in cycle 4 (2012-09-26); assessed as not related to study drug (unlikely); resolved 2012-10-02; action: drug interrupted.

severe assessed

Grade 1 cough with onset in cycle 2 (2012-08-14); assessed as not related to study drug (unlikely); resolved 2012-09-07.

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.